| Issue |
Date |
Articles |
|
Issue 29 Click here
|
07/12/21
|
- Update of Methotrexate 10mg Prescribing
- Accu-Chek Instant test strips
- Inclisiran Update
- Shingles Update
- Afghan Primary Care Guidance
- Inhaler Spacers
- Champix Supply Alert
- Proxy Access for care homes
- Herbal and Homeopathic Resources
- MHRA alerts
- Palliative Pharmacy List update
|
|
Issue 28 Click here
|
28/10/21
|
- Sodium Valproate Safety Alert
- World Antimicrobial Awareness Week (WAAW)
- Changes to NHS System Oversight Framework (SOF) Antimicrobial Prescribing Metrics for 2021-22
- Choosing a suitable antidepressant for people with coronary heart disease (CHD)
- Sativex Shared Care reminder
- PharmOutcomes/Outcomes4Health
- Palliative Care Medicines Supply from Community Pharmacies
- Repeat Prescribing Recommendation
- Update to Medicines Optimisation Scheme
- Additional Roles Reimbursement Scheme (ARRS) Funding
- MHRA Drug Safety Update September 2021
|
|
Issue 27 Click here
|
30/09/21
|
- Steroid Emergency Card
- Lidocaine Plaster Position Statement
- Documenting Warfarin Prescribed by a Third Party on GP Notes
- NICE TA 694 Bempedoic Acid/Ezetimibe
- Unseasonal Rise in Amoxicillin Prescribing for Children in Primary Care
- Choosing Formulations of Medicines for Adults with Swallowing Difficulties
- Community Pharmacy Contractual Framework 2021/22
- CQC Inspections – Clinical System Prescribing Searches
- MHRA Drug Safety up-date August 2021
|
|
Issue 26 Click here
|
26/08/21
|
- Hydroxychloroquine Eye Screening
- Clexane ® (enoxaparin sodium) device differences between PREVENTIS and ERIS needle guard safety systems.
- Antimicrobial Prescribing For UTIs - Resources to help reduce the impact of antibiotic resistance
- First progesterone-only contraceptive pills available to purchase from pharmacies
- Vaccination Reimbursement
- MHRA Drug Safety Update July 2021
- Local ICP Update
|
|
Issue 25 Click here
|
22/07/21
|
- NHS England & Improvement Letter to women and girls taking sodium valproate
- Liothyronine Implementation
- Semaglutide (Ozempic) injectable- reminder on quantitiesfor prescribing
- Chloramphenicol eye drops containing borax or boric acid buffers: use in children younger than 2 years
- Inappropriate anticoagulation of patients with a mechanical heart valve
- MHRA safety warning: Herbal products containing Butterbur
- MHRA Drug Safety Update June 2021
- Vaccine Hesitancy
|
|
Issue 24 Click here
|
28/06/21
|
- Recording of medications on EMIS -‘hospital only’ or medications from other providers
- Kent and Medway Formulary Update
- Women’s safety and domestic abuse during COVID-19:a reminder of advice for NHS staff
- Freestyle Libre Sensor Replacement
- Sativex Shared Care
- Four Month free Vitamin D Supply for Care homes
- MHRA Drug Safety Update May 2021
- Local ICP Update
|
|
Issue 23 Click here
|
28/05/21
|
- Management of patients who have constipation when taking Clozapine
- Valproate Pregnancy Prevention Programme
- Medicines in pregnancy and breastfeeding: new initiative for consistent guidance
- Detailed Guidance to Support Implementation of National Patient Safety Alert
- Shared Care with Private Providers
- Saxenda for weight loss
- GMC Guidance
- MHRA Drug Safety Update April 2021
|
|
Issue 22 Click here
|
30/04/21
|
- KMCCG Position on Methotrexate 10mg Prescribing
- Covid-19 and use of inhaled budesonide for adults (50 years and over)
- Practices Advised to Redirect Cancard Requests
- Kent and Medway Formulary Update - Additions to the Kent and Medway Joint Formulary
- MHRA Drug Safety Update March 2021
- Local ICP Update
|
|
Issue 21 Click here
|
30/03/21
|
- Kent and Medway COVID -19 Vaccination Management of Allergies Policy
- MHRA response to the precautionary Suspensions of the Astra Zeneca COVID-19 Vaccine
- Covid 19 Vaccines and Fertility
- Updated GMC Guidance
- Stoma Accessories Formulary Update
- Antimicrobials (azithromycin and doxycycline) not beneficial in the management of COVID-19
- Pregabalin (Lyrica®): reports of severe respiratory depression
- SSRI/SNRI antidepressant use in pregnancy
|
|
Issue 20 Click here
|
25/02/21
|
- Drug Monitoring during the COVID-19 Pandemic
- Antiepileptic Drugs In Pregnancy: Updated Advice Following Comprehensive Safety Review
- PHE: Vitamin D and Care Homes Guidance
- Pandemic Delivery Service
- Long COVID
- NHS Diabetes Helpline
- Liraglutide 6mg/ml Injection/Saxenda® - not for Primary Care Prescribing
- Formulary Update: High Cost Drugs Manual
- ICP Update
|
